Compare SRL & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRL | XTNT |
|---|---|---|
| Founded | 2017 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0M | 86.2M |
| IPO Year | N/A | N/A |
| Metric | SRL | XTNT |
|---|---|---|
| Price | $9.01 | $0.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 35.6K | ★ 188.4K |
| Earning Date | 04-24-2026 | 03-05-2026 |
| Dividend Yield | ★ 11.49% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $26,224,099.00 | ★ $133,083,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $52.95 |
| Revenue Growth | N/A | ★ 16.88 |
| 52 Week Low | $5.13 | $0.34 |
| 52 Week High | $9.64 | $0.95 |
| Indicator | SRL | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 62.12 | 35.20 |
| Support Level | $8.78 | $0.60 |
| Resistance Level | $9.45 | $0.67 |
| Average True Range (ATR) | 0.57 | 0.04 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 74.20 | 6.76 |
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.